Announce Date | 02/20/2025 |
EPS Normalized Actual | $1.66 (Beat by $0.14) |
EPS GAAP Actual | $1.66 (Beat by $0.14) |
Revenue Actual | $1.01994B |
Revenue Surprise | Beat by $1019.94M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.77033 |
EPS GAAP Estimate | $1.77033 |
Revenue Estimate | $1.070817078B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 9.65 | 7.64 | 9.27199 | 9.99672 | 1 |
Dec 2028 | 9.95 | 7.41 | 9.77787 | 10.16056 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.93 | 0.93 | 1.01994B | 2.44% | 1019.94M |
FQ3 2024 (Sep 2024) | 1.22 | 1.22 | 1.00468B | 3.9% | 1004.68M |
FQ2 2024 (Jun 2024) | 0.86 | 0.86 | 0.97958B | 4.48% | 979.58M |
FQ1 2024 (Mar 2024) | 1.16 | 1.16 | 0.98697B | 7.22% | 986.97M |
FQ4 2023 (Dec 2023) | 1.03 | 1.03 | 0.995017B | 6.76% | 995.02M |
FQ3 2023 (Sep 2023) | 1.06 | 1.06 | 0.965484B | 8.66% | 965.48M |
FQ2 2023 (Jun 2023) | 0.85 | 0.85 | 0.935721B | 3.46% | 935.72M |
FQ1 2023 (Mar 2023) | 0.62 | 0.62 | 0.915698B | 100% | 915.7M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
1.77033
Consensus Revenue Estimates
1.070817078B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.88255 | -- | 1.84412 | 1.92386 | 5 |
FQ2 2027 (Jun 2027) | 1.78516 | -- | 1.74872 | 1.82433 | 5 |
FQ1 2027 (Mar 2027) | 1.82817 | -- | 1.79085 | 1.86828 | 5 |
FQ4 2026 (Oct 2026) | 1.92667 | -- | 1.91143 | 1.95268 | 5 |
FQ3 2026 (Jul 2026) | 1.83 | -- | 1.81553 | 1.85471 | 5 |
FQ2 2026 (Jun 2026) | 2.05 | -- | 2.01769 | 2.08526 | 9 |
FQ1 2026 (Mar 2026) | 1.80333 | -- | 1.79405 | 1.82631 | 6 |
FQ4 2025 (Oct 2025) | 1.71539 | 45.78 | 1.70182 | 1.73855 | 11 |
FQ3 2025 (Jul 2025) | 1.66385 | 26.68 | 1.65069 | 1.68632 | 10 |
FQ2 2025 (Jun 2025) | 1.77033 | 51.42 | 1.74242 | 1.80078 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.2B | -- | 1.18B | 1.22B | 6 |
FQ2 2027 (Jun 2027) | 1.17B | -- | 1.15B | 1.19B | 6 |
FQ1 2027 (Mar 2027) | 1.16B | -- | 1.14B | 1.18B | 6 |
FQ4 2026 (Oct 2026) | 1.17B | -- | 1.16B | 1.18B | 10 |
FQ3 2026 (Jul 2026) | 1.13B | -- | 1.12B | 1.14B | 10 |
FQ2 2026 (Jun 2026) | 1.16B | -- | 1.14B | 1.17B | 10 |
FQ1 2026 (Mar 2026) | 1.11B | -- | 1.11B | 1.12B | 11 |
FQ4 2025 (Oct 2025) | 1.07B | 4.89 | 1.07B | 1.08B | 5 |
FQ3 2025 (Jul 2025) | 1.04B | 3.78 | 1.04B | 1.05B | 5 |
FQ2 2025 (Jun 2025) | 1.07B | 8.52 | 1.06B | 1.08B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.93 | 0.93 | 100% | |
FQ3 2024 (Sep 2024) | 1.22 | 1.22 | 100% | |
FQ2 2024 (Jun 2024) | 0.86 | 0.86 | 100% | |
FQ1 2024 (Mar 2024) | 1.16 | 1.16 | 100% | |
FQ4 2023 (Dec 2023) | 1.03 | 1.03 | 100% | |
FQ3 2023 (Sep 2023) | 1.06 | 1.06 | 100% | |
FQ2 2023 (Jun 2023) | 0.85 | 0.85 | 100% | |
FQ1 2023 (Mar 2023) | 0.62 | 0.62 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1.02B | $1019.94M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1B | $1004.68M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.98B | $979.58M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.99B | $986.97M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1B | $995.02M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.97B | $965.48M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.94B | $935.72M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.92B | $915.7M | 100% |